Westfield Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
CIP
BCM
Westfield Capital Management's RGEN Position: Q3 2024 in Review
Westfield Capital Management sold out of Repligen (RGEN) in Q3 2024, closing a stake of 255,762 shares — an estimated $32.2M sold.
Westfield Capital Management first reported a position in RGEN in Q4 2019 and held it in 16 quarters. The position peaked at $52.9M in Q4 2023. 444 funds tracked by Wall St. Rank hold RGEN as of Q3 2024.
- Westfield Capital Management reported no remaining Repligen position as of Q3 2024 after selling out during the quarter.
- Westfield Capital Management sold 255,762 Repligen shares in Q3 2024, an estimated $32.2M.
- Westfield Capital Management first reported a position in Repligen in Q4 2019 and held it in 16 quarters.
- Westfield Capital Management's Repligen position peaked at $52.9M in Q4 2023.
- 444 funds tracked by Wall St. Rank held Repligen as of Q3 2024.
Based on Westfield Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.